Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeted therapies: LUX-Lung trials-not all mutations are created equal.

Nature reviews. Clinical oncology - 1 Mar 2015

Hutchinson Lisa

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Antineoplastic Combined Chemotherapy Protocols
Share to ErbB Receptors
Share to Lung Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Quinazolines

Source

Identifiers

PMID: 25622977
DOI: 10.1038/nrclinonc.2015.9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeted therapies: LUX-Lung trials-not all mutations are created equal.PMID 25622977Read ↗

[From ASCO and WCLC 2005 to the clinical practice: targeted therapies].Semantic proximity Read ↗

From mutation identification to therapy: discovery and origins of the first approved gene therapy in the Western world.Semantic proximity Read ↗

Lung cancer: not just for smokers. People who never smoked may have a different form of the disease that responds better to a new generation of targeted medications.Semantic proximity Read ↗

Pulmonary genetics, genomics, and gene therapy: conference summary.Semantic proximity Read ↗

[Responses to targeted therapies: lung cancer].Semantic proximity Read ↗

Many mutations in one clinical-trial basket.Semantic proximity Read ↗

Tailored targeted therapy for all: a realistic and worthwhile objective?Semantic proximity Read ↗

Achieving personalized cancer medicine: trials and tribulations.Semantic proximity Read ↗

Lung cancer: Functional insights into cancer mutations-eVIP approach.Semantic proximity Read ↗

Driving genotype treatment options down the right path(way).Semantic proximity Read ↗

Second-line therapy in non-small-cell lung cancer: the DELTA between different genotypes widens.Semantic proximity Read ↗

The Cystic Fibrosis mutation "arms race": when less is more.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.